These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17721002)

  • 1. The mechanism of overcoming multidrug resistance (MDR) of fungi by amphotericin B and its derivatives.
    Slisz M; Cybulska B; Grzybowska J; Czub J; Prasad R; Borowski E
    J Antibiot (Tokyo); 2007 Jul; 60(7):436-46. PubMed ID: 17721002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on cell stimulatory, permeabilizing and toxic effects induced in sensitive and multidrug resistant fungal strains by amphotericin B (AMB) and N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
    Szlinder-Richert J; Cybulska B; Grzybowska J; Borowski E; Prasad R
    Acta Biochim Pol; 2000; 47(1):133-40. PubMed ID: 10961686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
    Sharma M; Prasad R
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4834-43. PubMed ID: 21768514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole and multidrug resistance in Candida albicans.
    Wakieć R; Prasad R; Morschhäuser J; Barchiesi F; Borowski E; Milewski S
    Mycoses; 2007 Mar; 50(2):109-15. PubMed ID: 17305773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of amphotericin B and its low toxic derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester, with fungal, mammalian and bacterial cells measured by the energy transfer method.
    Szlinder-Richert J; Cybulska B; Grzybowska J; Bolard J; Borowski E
    Farmaco; 2004 Apr; 59(4):289-96. PubMed ID: 15081346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced susceptibility to antifungal oligopeptides in yeast strains overexpressing ABC multidrug efflux pumps.
    Wakiec R; Gabriel I; Prasad R; Becker JM; Payne JW; Milewski S
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4057-63. PubMed ID: 18794383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine.
    Paquet V; Carreira EM
    Org Lett; 2006 Apr; 8(9):1807-9. PubMed ID: 16623556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
    Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
    Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae.
    da Rocha Curvelo JA; Reis de Sá LF; Moraes DC; Soares RM; Ferreira-Pereira A
    J Mycol Med; 2018 Mar; 28(1):137-142. PubMed ID: 29217144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance in yeasts--an emerging scenario.
    Prasad R; Panwar SL; Smriti
    Adv Microb Physiol; 2002; 46():155-201. PubMed ID: 12073653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
    Cybulska B; Kupczyk K; Szlinder-Richert J; Borowski E
    Acta Biochim Pol; 2002; 49(1):67-75. PubMed ID: 12136958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine enhances the effect of amphotericin B against Candida albicans in vitro.
    Zhao L; Jiang J; Zhu Z; Liao Z; Yao X; Yang Y; Cao Y; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):182-93. PubMed ID: 26711896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.
    Parmegiani RM; Loebenberg D; Antonacci B; Yarosh-Tomaine T; Scupp R; Wright JJ; Chiu PJ; Miller GH
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1756-60. PubMed ID: 3324961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement effect of N-methyl-N″-dodecylguanidine on the vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans.
    Yutani M; Ogita A; Usuki Y; Fujita K; Tanaka T
    J Antibiot (Tokyo); 2011 Jul; 64(7):469-74. PubMed ID: 21522157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system.
    Ogita A; Fujita K; Taniguchi M; Tanaka T
    Planta Med; 2006 Oct; 72(13):1247-50. PubMed ID: 16902870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative susceptibility of Candida albicans to amphotericin B and amphotericin B methyl ester.
    Bannatyne RM; Cheung R
    Antimicrob Agents Chemother; 1977 Oct; 12(4):449-50. PubMed ID: 335958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efflux pumps in drug resistance of Candida.
    Prasad R; Gaur NA; Gaur M; Komath SS
    Infect Disord Drug Targets; 2006 Jun; 6(2):69-83. PubMed ID: 16789872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.